Free Trial

Orthofix Medical Q3 2023 Earnings Report

Orthofix Medical logo
$17.43 +0.24 (+1.40%)
(As of 12/20/2024 05:16 PM ET)

Orthofix Medical EPS Results

Actual EPS
-$0.77
Consensus EPS
-$0.75
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Orthofix Medical Revenue Results

Actual Revenue
$184.01 million
Expected Revenue
$185.50 million
Beat/Miss
Missed by -$1.49 million
YoY Revenue Growth
N/A

Orthofix Medical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

Orthofix Medical Earnings Headlines

Orthofix to Participate in Upcoming Investor Conferences
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
Orthofix price target raised to $22 from $20 at Roth MKM
See More Orthofix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Orthofix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orthofix Medical and other key companies, straight to your email.

About Orthofix Medical

Orthofix Medical (NASDAQ:OFIX) operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

View Orthofix Medical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings